Abstract
Changes in hepatitis C virus antibody titer and viral RNA load in non‐Hodgkin’s lymphoma patients after rituximab chemotherapy
Highlights
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation
The HCV-RNA load increased gradually elevated after the administration of R-CHO or R-THP-CO (THP-COP without predonisolone)
We previously reported changes in the titers of antibodies to HBsAg and to hepatitis B core antigen that were due to treatment with chemotherapy and rituximab (Tsutsumi et al, 2005)
Summary
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. R-CHO (CHOP without predonisolone) and was decreased after the administration of CHO (without rituximab). The HCV-RNA load was elevated only after the administration of rituximab. The HCV-RNA load increased gradually elevated after the administration of R-CHO or R-THP-CO (THP-COP without predonisolone).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.